The Global Next Generation Sequencing Market is poised to grow strong during the forecast period 2017 to 2027.
Some of the prominent trends that the market is witnessing include increasing adoption in clinical workflows, growing demand for high-accuracy forensic tools and increasing incidence of chronic diseases.
Based on technology, the market is categorised into Whole Exome Sequencing, Whole Genome Sequencing, Targeted Sequencing & Resequencing, Ion Semiconductor Sequencing, Nanopore Sequencing, Sequencing by Synthesis, Single-Molecule Real-Time Sequencing, Chromatin Immunoprecipitation (CHIP) Sequencing, Methyl Sequencing, De Novo Sequencing, Pyrosequencing, Sequencing by Ligation (SBL) and Reversible Terminator Sequencing. Targeted Sequencing & Resequencing is sub divided into Deoxyribonucleic Acid (DNA)-based Targeted Sequencing & Resequencing and Ribonucleic Acid (RNA)-based Targeted Sequencing & Resequencing.
By mode, the market is fragmented into outsourced data analysis and in-house data analysis.
On the basis of product, the market is segregated into NGS Services, NGS Commercial Software, Instruments, Kits & Consumables and Software. NGS Commercial Software segment is sub divided into Platform OS/UI and Analytical software. Instrument segment is further divided into integrated workflow instruments and library preparation instruments. Kits & Consumables segment is sub divided into library preparation kits, multiuse kits, target enrichment kits and sequencing kits.
Depending on application, the market is segmented into drug discovery, agricultural & animal research, diagnostics, clinical investigation, Human Leukocyte Antigen (HLA) Typing/Immune System Monitoring, agrigenomics & forensics, consumer genomics, metagenomics, epidemiology & drug development, reproductive health and Biomarker Discovery. In addition Diagnostics segment is further categorised into Infectious Disease Diagnostics, Reproductive Health Diagnostics, Cancer Diagnostics and Other Diagnostic Applications. Clinical Investigation segment is sub divided into Inherited Diseases, Idiopathic Diseases and Non-communicable/Other Diseases. Reproductive Health segment is further segregated into Preimplantation Genetic Testing (PGT), Noninvasive Prenatal Testing (NIPT) and Single Gene Analysis.
Based on end user, the market is classified into hospitals & clinics, academic institutes & research centers, pharmaceutical & biotechnology companies and other end users.
This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2015, 2016 revenue estimations are presented for 2017 and forecasts from 2018 till 2027. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants, and the future investors.
The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub-segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.
This report provides data tables, includes charts and graphs for visual analysis.
Regional Analysis: North America - US - Canada - Mexico
Europe - France - Germany - Italy - Spain - UK - Rest of Europe
Asia Pacific - China - Japan - India - Australia - New Zealand - Rest of Asia Pacific
Middle East - Saudi Arabia - UAE - Rest of Middle East
Latin America - Argentina - Brazil - Rest of Latin America
Rest of the World - South Africa - Others
Report Highlights: - The report provides a detailed analysis of current and future market trends to identify the investment opportunities - Market forecasts till 2027, using estimated market values as the base numbers - Key market trends across the business segments, Regions and Countries - Key developments and strategies observed in the market - Market Dynamics such as Drivers, Restraints, Opportunities and other trends - In-depth company profiles of key players and upcoming prominent players - Growth prospects among the emerging nations through 2027 - Market opportunities and recommendations for new investments
Our reports have been used by over 10K customers, including:
224 pages •
By The Business Research Company
• Dec 2020
Next Generation Sequencing Global Market Opportunities And Strategies 2020-30: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global next generation sequencing market. Description: Where is the largest and fastest growing...
The global metabolomics market size is projected to reach USD 4.1 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 13.4% during the forecast period. The major factors driving the growth of this market are the growing R&D expenditure in the pharmaceutical & biopharmaceutical industry, growing demand for personalized medicine and increasing...
Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Immunochemistry Analyzers pipeline products with comparative analysis of...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global dPCR and qPCR Market Report The dPCR and qPCR market by revenue is expected to grow at a CAGR of over 9% during the period 2020–2025. The global digital PCR (dPCR) and the real-time PCR (qPCR) market is one of the dynamic and fast-growing...
Parasitology and Mycology Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Parasitology and Mycology Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Parasitology & Mycology Tests pipeline products with comparative...
The nucleic acid amplification, detection, and diagnostics market was valued at US$ 14,014.59 million in 2019 and is projected to reach US$ 38,162.68 million by 2027; it is expected to grow at a CAGR of 13.4% during 2020–2027. The growth of the nucleic acid amplification, detection, and diagnostics market is mainly attributed to the factors...
The Asia Pacific single-cell analysis market is projected to reach USD 1,375 million by 2025 from USD 550 million in 2020, at a CAGR of 20.1% during the forecast period. Market growth is driven by factors such as growth in stem cell research, increasing R&D in the pharmaceutical and biotechnology industries for complex diseases, rising prevalence...
525 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Nov 2020
Genomics is the branch of biotechnology where different techniques of genetics and molecular biology are employed to map the DNA sequences of targeted genes or the complete set of genomes of interest and then organizing the results in the database and application of data in various fields. Genomics technologies are...
The RNA analysis/transcriptomics market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period. The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.